GoodRx Holdings, Inc. (GDRX): Price and Financial Metrics

GoodRx Holdings, Inc. (GDRX): $6.16

0.24 (+4.05%)

POWR Rating

Component Grades














  • GDRX scores best on the Growth dimension, with a Growth rank ahead of 92.29% of US stocks.
  • The strongest trend for GDRX is in Growth, which has been heading up over the past 179 days.
  • GDRX's current lowest rank is in the Stability metric (where it is better than 12.76% of US stocks).

GDRX Stock Summary

  • With a one year PEG ratio of 290.4, GoodRx Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 91.38% of US stocks.
  • GoodRx Holdings Inc's stock had its IPO on September 23, 2020, making it an older stock than merely 2.81% of US equities in our set.
  • Price to trailing twelve month operating cash flow for GDRX is currently 43.03, higher than 87.69% of US stocks with positive operating cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to GoodRx Holdings Inc are AEYE, CDLX, DOCU, RNG, and KLR.
  • Visit GDRX's SEC page to see the company's official filings. To visit the company's web site, go to

GDRX Valuation Summary

  • GDRX's EV/EBIT ratio is -40.7; this is 226.2% lower than that of the median Technology stock.
  • Over the past 49 weeks, GDRX's EV/EBIT ratio has gone down 224.3.
  • Over the past 49 weeks, GDRX's EV/EBIT ratio has gone down 224.3.

Below are key valuation metrics over time for GDRX.

Stock Date P/S P/B P/E EV/EBIT
GDRX 2021-09-01 23.8 18.2 -47.8 -40.7
GDRX 2021-08-31 23.8 18.2 -47.9 -40.7
GDRX 2021-08-30 23.1 17.7 -46.3 -39.4
GDRX 2021-08-27 23.3 17.9 -46.9 -39.9
GDRX 2021-08-26 22.2 17.0 -44.6 -37.9
GDRX 2021-08-25 22.7 17.4 -45.6 -38.7

GDRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • GDRX has a Quality Grade of C, ranking ahead of 38.44% of graded US stocks.
  • GDRX's asset turnover comes in at 0.413 -- ranking 365th of 563 Business Services stocks.
  • 500 - Internal server error

The table below shows GDRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.413 0.939 -0.432
2020-12-31 0.593 0.946 -0.344

GDRX Price Target

For more insight on analysts targets of GDRX, see our GDRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $43.07 Average Broker Recommendation 1.64 (Moderate Buy)

GDRX Stock Price Chart Interactive Chart >

Price chart for GDRX

GDRX Price/Volume Stats

Current price $6.16 52-week high $48.05
Prev. close $5.92 52-week low $5.61
Day low $5.89 Volume 1,274,600
Day high $6.17 Avg. volume 2,530,760
50-day MA $9.09 Dividend yield N/A
200-day MA $25.89 Market Cap 2.44B

GoodRx Holdings, Inc. (GDRX) Company Bio

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

GDRX Latest News Stream

Event/Time News Detail
Loading, please wait...

GDRX Latest Social Stream

Loading social stream, please wait...

View Full GDRX Social Stream

Latest GDRX News From Around the Web

Below are the latest news stories about GoodRx Holdings Inc that investors may wish to consider to help them evaluate GDRX as an investment opportunity.

GoodRx to Present at Upcoming Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings Inc. (Nasdaq: GDRX), a leading consumer-focused digital healthcare platform, today announced that executives from the Company will be presenting at the following investor conferences: Raymond James 43rd Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 8, at 7:25 a.m. Pacific Time (10:25 a.m. Eastern Time) Cowen 42nd Annual Health Care Conference will take place virtually on Wednesday, March 9, at 8:10 a.m. Pacific

Business Wire | February 22, 2022

GoodRx Holdings, Inc. (GDRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 21, 2022

AMN vs. GDRX: Which Stock Should Value Investors Buy Now?

AMN vs. GDRX: Which Stock Is the Better Value Option?

Yahoo | February 16, 2022

First Dallas Securities Inc. Buys American Eagle Outfitters Inc, Ethan Allen Interiors Inc, New ...

Dallas, TX, based Investment company First Dallas Securities Inc. (Current Portfolio) buys American Eagle Outfitters Inc, Ethan Allen Interiors Inc, New York Community Bancorp Inc, PayPal Holdings Inc, Pioneer Natural Resources Co, sells GoodRx Holdings Inc, Deutsche Bank AG, Encore Wire Corp, Nordstrom Inc, AT&T Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, First Dallas Securities Inc..

Yahoo | February 8, 2022

Load Up on These 2 Growth Stocks During This Market Correction

If an investor wants a well-balanced portfolio, they'll need to hold a couple of growth stocks that'll appreciate in value reliably for years on end. Both of the stocks I'll discuss today have had a punishing 12 months, and the recent market correction hasn't done them any favors. GoodRx (NASDAQ: GDRX) helps consumers cut down on their prescription costs by finding coupons for the lowest local prices for their medicines and negotiating with manufacturers, pharmacies, and other providers on their behalf.

Yahoo | February 3, 2022

Read More 'GDRX' Stories Here

GDRX Price Returns

1-mo -18.73%
3-mo -67.09%
6-mo -77.41%
1-year N/A
3-year N/A
5-year N/A
YTD -81.15%
2021 -18.99%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5129 seconds.